喜炎平治疗上呼吸道感染的临床体会

Clinical Experience of Xiyanping Medication Treatment for Upper Respiratory Tract Infection

目的分析喜炎平治疗上呼吸道感染的临床疗效。方法研究对象选取2014年8月~2015年8月本院上呼吸道感染患者40例,依照不同治疗药物分组。对照组药物为利巴韦林,共20例;给予余20例喜炎平治疗,入组实验组。观察评定疗效,组间比较。结果组间相比,实验组治疗有效率较高,发热及咳嗽消失时间短,差异有统计学意义（P〈0.05）。结论上呼吸道感染治疗时应用喜炎平,疗效确切。

Objective Clinical effect of xiyanping medication in treatment of upper respiratory tract infection is to be studied. Methods 40 patients of upper respiratory tract infection who are treated in hospital from August 2014 to August 2015 were chosen and separate them into two groups according to different medication treatments, 20 patients in control group are given ribavirin medication treatment, while another 20 patients in study group are given xiyanping medication treatment, and then compare treatment effects between two groups. Results Patients＇ treatment efficacy in study group is much higher than that in control group, besides, patients＇ fever and cough abatement time in study group is much shorter, there is a differential between two groups and such a differential has statistic value（P〈0.05）. Conclusion Xiyanping is effective in treatment of upper respiratory tract infection, thus, such a treatment is quite worthwhile to be promoted.